Skip to main content
  • Saved

Differential Glycaemic Control With Basal Insulin Glargine 300 U/mL Versus Degludec 100 U/mL According to Kidney Function in Type 2 Diabetes: A Subanalysis From the BRIGHT Trial - PubMed

Differential Glycaemic Control With Basal Insulin Glargine 300 U/mL Versus Degludec 100 U/mL According to Kidney Function in Type 2 Diabetes: A Subanalysis From the BRIGHT Trial - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/32243043/

doi: 10.1111/dom.14043. Online ahead of print. 1 Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. 2 Department of Medicine, University of Toronto, Toronto, Ontario, Canada. 3 Department of Cardiology, University Hospital RWTH Aachen, Aachen, Germany. 4 Sanofi, Paris, France. 5 Ividata, Levallois-Perret, France.